PCM
MRTX

Penserra Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Penserra Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-380
Closed -$63K – 1145
2020
Q3 		$63K Buy
+380
New +$63K ﹤0.01% 610